Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. - Wikidata - wikimedia - TriplyDB

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

http://www.wikidata.org/entity/Q39392164

about

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies The temporal impact of aging on the burden of herpes zoster.Herpes zoster and the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis.QnAs with Rino Rappuoli.Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States.Issues in vaccinology: Present challenges and future directions.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.New treatment strategies for ulcerative colitis.Assessment of the potential public health impact of Herpes Zoster vaccination in Germany.Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.The alpha-herpesviridae in dermatology : Varicella zoster virus.Successful and Maladaptive T Cell Aging.Vaccine development for respiratory syncytial virus.Human T cell immunosenescence and inflammation in aging.CNS Infections: A new herpes zoster subunit vaccine for older adults.Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.Personalized vaccinology: A review.The health threats to people with asthma through asthma-associated infectious disease comorbidities are largely under-recognized.Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy.Herpes zoster - typical and atypical presentations.Vaccine profile of herpes zoster (HZ/su) subunit vaccine.A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).[The alpha-herpesviridae in dermatology : Varicella zoster virus. German version].Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.Varicella Virus Vaccination in the United States.Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine.Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's Disease.Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging.Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.Post-herpetic neuralgia - a review of current management and future directions.Vaccines for the elderly: current use and future challenges.Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.Dermatological Complications After Solid Organ Transplantation.

P2860

Q33724403-93993B23-05F0-4391-9A64-F99558B717E6 Q33891821-8BC158B3-362D-48AF-BFC6-03C7938A460C Q36257901-B8FEB16C-7D53-4DB2-AC91-A60A51A0566A Q36274078-FA2FB455-0CEB-4BD6-8D4C-3CB9787B4801 Q37612490-74C34D0B-B68B-4BA9-B396-91A5636F2E7D Q38375698-8B861953-4EBF-42B7-9706-3CE4D46BBABE Q38634551-6951551C-FD6E-40B8-B2E6-54134FA0593B Q38638518-EBB02A36-96B1-4F22-AAC3-2EACA50F6142 Q38670811-030E077F-05C8-48D8-A4E4-DA7BE0FC435D Q38678770-96681860-9BB7-4F05-AE59-074498D29507 Q38804622-8328AF85-8ADF-4B5F-8047-F1128305362B Q39135860-F1506D13-A0BE-4C5E-B52E-D1CDA52EB806 Q39193878-B516614C-F5E2-4180-80D7-568D3D6E88E1 Q39318444-74255179-5CEA-4093-AD13-CBD192A8E381 Q39451386-2453425A-D67D-4DA7-B698-EB53B7D4CF16 Q39579533-151E806B-722A-48D3-A75A-A5AA6B89E50D Q40064119-012C8A2F-9D84-46BD-A849-C16460EC66CB Q40107665-FCA3A0EA-D445-4CBD-82FA-27814FE34BCC Q40141814-B81C5CC1-6FE1-4B32-97DC-53ACEBFB7320 Q40175407-A23F7FC5-9EA8-4609-8C1E-AEF7CE0D0BA2 Q40187065-A4778F38-0E6D-439C-A52C-D5F6C7F083CC Q40208840-F7C3E218-61C7-404B-BCB1-37F7764B2C35 Q40210971-4B774300-051D-4138-A2BB-90534E045BA7 Q40223016-427D05EB-053B-400E-ACD4-B47E8F52F1AC Q40234780-9C58E496-F05A-4A22-805E-D2DF42213ECC Q40322523-3562CB1A-85D7-4832-9883-68EC5F4BB5B3 Q40335969-D442F671-84C0-41DC-921E-F1312BD48BFE Q43646903-3C14F6DD-32AA-4316-9E14-BB3961D11D4F Q45066717-B3AE4AE6-227A-4ABC-8FB3-B6DF32538469 Q45324301-A045F938-DFE8-401D-9FF1-A2E09D815BB0 Q46046365-6A268A2E-CA8D-4803-AFB6-531A8D97B03F Q46572613-CD37A192-9087-4FEE-A820-C090EFA25EAF Q46892547-0ECBA8F3-6500-4576-B192-8E4786F4B517 Q47105115-D2A89C98-23FB-4B5F-96E2-01295EE4AFDC Q47140159-2EFE534A-6630-4224-A02A-DB351AD0D1C0 Q47216309-96C9D34D-E182-40E9-8558-58A63748C63E Q47242634-58977BE4-2902-4D66-86C9-BA752DF5E6AE Q47547388-36BC7419-D5E2-4419-BAA7-3805830A1556 Q47556386-CAAADCEB-BE4B-4F7F-A0CE-3E74D9B88A98 Q47572587-4EAD3DD1-1D4D-47B9-A8C9-E873A7432DF8

P2860

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

http://www.wikidata.org/entity/Q39392164

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

@en

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

@nl

type

label

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

@en

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

@nl

prefLabel

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

@en

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

@nl

P1433

Q39392164-13D0D244-6014-4758-B853-6D84A9BB1438

P1476

Q39392164-AAB73FE9-893F-441E-8EFF-270369807A9F

P2093

Q39392164-0C684201-C647-4B76-93D2-79A658446A48

Q39392164-11280DB2-7695-464D-A072-8E87C6F22C26

Q39392164-14EBFECD-2EE3-4808-A8CB-A9E57D6677CC

Q39392164-16F7E0B3-CC18-4A92-84DB-CA9E60152E92

Q39392164-18FCAF52-9784-4179-B272-3263A719080D

Q39392164-27120B4E-DA8B-4A31-B02B-B67C07BB76D5

Q39392164-2A6916FE-4BCD-49D1-BBAD-CBB9C71A4B4E

Q39392164-2DF5CDDB-BF3D-4479-B4D7-E089D3387165

Q39392164-2FD3AF21-AFE0-49DE-99F9-3BA743AEDFF2

Q39392164-39C96CDD-77C3-40ED-9D62-19728F0E60B9

P304

Q39392164-AFE1D664-6B8A-41C4-B561-DAAA44798FC6

P31

Q39392164-91B5E244-2595-4046-8CEB-25B1EE3FB9A3

P356

Q39392164-BDC28EE3-300D-4DC2-B16E-2B4FBCFD357E

P407

Q39392164-990C05E3-8184-4BBA-B05C-9CAA28EF7486

P433

Q39392164-6DF3950A-CFD0-457A-BE02-23D1E6571B66

P478

Q39392164-0C043C35-2C5F-4212-8AA9-3DA7EE39B84B

P577

Q39392164-0309DAF2-745D-40D5-99D4-AC99C60243EA

P698

Q39392164-55276FF2-0514-4AF7-B2B0-089CC8522398

P356

P1433

The New England Journal of Medicine

P1476

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

@en

P2093

Anitta Ahonen

http://www.w3.org/2001/XMLSchema#string

Anthony L Cunningham

http://www.w3.org/2001/XMLSchema#string

Carline Vanden Abeele

http://www.w3.org/2001/XMLSchema#string

Daisuke Watanabe

http://www.w3.org/2001/XMLSchema#string

Edward Leung

http://www.w3.org/2001/XMLSchema#string

Eugene Athan

http://www.w3.org/2001/XMLSchema#string

Ferdinandus de Looze

http://www.w3.org/2001/XMLSchema#string

H Jackson Downey

http://www.w3.org/2001/XMLSchema#string

Himal Lal

http://www.w3.org/2001/XMLSchema#string

Iris Gorfinkel

http://www.w3.org/2001/XMLSchema#string

P304

1019-1032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1603800

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

375

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27626517

http://www.w3.org/2001/XMLSchema#string